RT Journal Article
SR Electronic
T1 Genetic Causes of early onset Ataxia: Experience from the National Sheffield Paediatric Ataxia Centre
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.03.24309227
DO 10.1101/2024.07.03.24309227
A1 Garrard, K
A1 Beauchamps, N
A1 Connolly, DJA
A1 Secker, S
A1 Allen, K E
A1 Campbell, S
A1 Panayi, M
A1 Hadjivassiliou, M
A1 Mordekar, SR
YR 2024
UL http://medrxiv.org/content/early/2024/07/03/2024.07.03.24309227.abstract
AB Early onset cerebellar ataxias are sufficiently distinct in aetiology and disease course from adult onset ataxias to warrant independent evaluation. It has long been assumed that complex (multisystem) ataxias are more frequent in the paediatric ataxia population but the proportion of genetic causes and the makeup of this group of patients has not previously been examined in detail.Data from 704 patients from the Sheffield Paediatric Ataxia Centre (SPAC) confirms Friedriech’s ataxia as the most common genetic paediatric ataxia (25%) but this is closely followed by CACNA1A mutations (18.2%). Pick up rate was higher than for adult populations and recessive and dominant conditions were represented in roughly equal proportions. A large proportion of mutations were only found in a single gene and nearly half of the NGS variants identified (46.7%) were variants of unknown significance (VUS). In total 13.8% of this population had a genetic cause confirmed. This demonstrates the utility of large gene panel testing in the paediatric ataxia population and highlights the need for further research and developments into determination of the pathogenicity of genetic variants.In conclusion, simple mendelian genetic diseases are responsible for a significant proportion of cases of chronic ataxia in the paediatric cohort.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is affiliated with the Sheffield Childrens Hospital and Sheffield Hallam University. This study was registered with the clinical governance team (Keith Pugh - research and development manager) as a service evaluation project at the Sheffield Childrens Foundation Trust and as such was deemed to not require ethical approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available in an anonymised format upon reasonable request to the authors